LTZ Therapeutics

Bioscience & Disease Healthcare Systems

Website LinkedIn Beijing , Beijing , China

About LTZ Therapeutics

LTZ Therapeutics is an immunotherapy-focused global biotech startup dedicated to developing myeloid engagers for clinical trials, particularly in the fields of oncology and autoimmune diseases.

Business Information

Target Customers

healthcare providers research institutions pharmaceutical companies

Industry Categories

Bioscience & Disease Healthcare Systems

Business Model

Revenue Model Biotech licensing and partnerships

Pricing Strategy Not applicable (clinical trials)

Sales Channels direct partnerships, collaborations with research institutions

Funding Timeline

Round	Date	Amount	Investors
Series A	Apr 24, 2025	$40.0M	Unknown

Founders

No founder information available.

Investors

No investor information available.

Recent Mentions

Minhua Chu @chuminhua432

Apr 24, 2025

🇨🇳 bio #LTZ Therapeutics announced the oversubscription and successful completion of its Series A+ #financing round, raising a total of $40 million. The newly raised funds will primarily support the Ph1 clinical trial of its lead candidate, LTZ-301 — a FIC myeloid engager https://t.co/1b2qM03BUi

View on Twitter

Similar Startups

Granite Bio

83% match

Granite Bio is focused on developing immunology assets, pioneering a new approach to tackling inflam...

Healthee

81% match

Provider of an AI-powered platform for health benefits experiences, simplifying healthcare navigatio...

HexaHealth

81% match

HexaHealth is a healthcare startup focused on providing innovative solutions to improve patient care...

Listen Labs

80% match

Listen Labs is an autonomous market research platform that leverages AI to conduct customer intervie...